Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline with Temozolomide and Radiation in Newly Diagnosed High Grade Glioma
NCT02272270Phase 1Completed
- Sponsor
- University of Utah
- Start
- Oct 2014
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of minocycline in high-grade glioma (HGG), sponsored by University of Utah. Primary endpoint: Safety and tolerability of minocycline combined with standard radiation and chemotherapy at 14 months. Started Oct 2014; status: completed.
02
Drugs
minocycline
03
Conditions
high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT02272270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02272270.